Abstract:OBJECTIVE: The expression of S100A6 (calcyclin), a member of the S100 calcium binding protein family, is elevated in a number of malignant tumors, but there have been few reports about its expression in gastric cancer. The aim of this study was to investigate its expression regulations in human gastric cancer and noncancerous mucosa, and the response to chemotherapeutic drugs in the gastric cancer cell line.MATERIALS AND METHODS: In one matched gastric cancer sample pair, the serial analysis of gene expression (SAGE) experiment was conducted to compare the gene expression profiles between cancerous and adjacent tissues. To detect the expression regulations among more cancerous tissues, microarrays were carried out and real-time RT-PCR was conducted to validate the results. At the protein level, Western blot and tissue microarray (TMA) examination were further used to verify S100A6 expression. The regulation. detection of S100A6 with flurouracil and doxorubicin at the mRNA and protein level was performed in the SGC7901 cell line.RESULTS: With the SAGE strategy, five times more S100A6 tags were identified in cancer tissues than in normal tissues. With the cDNA microarray, S100A6 was found to be significantly upregulated in 21 of 42 (50%) nonselective gastric cancers. In 10 other paired samples, the upregulation of S 100A6 was consolidated with RT-PCR and Western blot analysis as well. A total of 14 endoscopy-sectioned gastric noncancerous lesions and corresponding normal gastric mucosa were also applied to profile the gene expression; both cDNA microarray and RT-PCR demonstrated no significant alterations of S 100A6 at the mRNA level. TMA examination showed that 34 of 52 (65.4%) cancer samples were positively stained, while only 17 of 80 (21.3%) noncancerous lesions were positively detected and all nine normal mucosae were detected to be negative. An in vitro experiment showed that in the gastric cell line SGC-7901, S100A6 mRNA was detected to be upregulated from 24 to 72 h after treatment with 5 mg/L 5-flurouracil or 0.3 mg/L doxorubicin, and there were two wave upregulations of the S100A6 protein.CONCLUSION: The observed regulated expression of S100A6 suggests that it is associated with gastric cancer tumorigenesis and quantitation of S100A6 is a promising tool for diagnosis of gastric cancer.

[Nuclear Expression of S100A4 is Associated with Lymph Node Metastasis in Gastric Carcinoma].

[Expression and Clinical Significance of CD44v6 and Scd44v6 in Gastric Carcinoma].

[Correlations of S100A4 Protein Expression to Invasion and Metastasis of Non-Small Cell Lung Cancer].

S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer.

Expressions of S100A4 in lung cancer tissues and its clinical significance

Nuclear Expression of S100a4 is Associated with Aggressive Behavior of Epithelial Ovarian Carcinoma: an Important Autocrine/Paracrine Factor in Tumor Progression

The expression and biological significance of S100A6 protein in gastric carcinoma tissue

Expression of Matrix Metalloproteinase-9 and Their Correlation with Tumor Invasion, Metastasis in Gastric Carcinoma

[Regulation Mechanism Study of S100A6 on Invasion and Metastasis in Gastric Cancer].

Presence of S100A9-positive Inflammatory Cells in Cancer Tissues Correlates with an Early Stage Cancer and a Better Prognosis in Patients with Gastric Cancer

The Expression of S100A4 Protein in Tumor-stroma of Human Non-small Cell Lung Cancer and Its Clinical Significance

[Clinical Significance of S100A8 and S100A9 Expression in Gastric Cancer].

S100a6 Overexpression is Associated with Poor Prognosis and is Epigenetically Up-Regulated in Gastric Cancer

Expression of S100A4 and matrix metalloproteinase 2 and their correlations with clinicopathological features in esophageal squamous cell carcinoma

Upregulated Expression Of S100a6 In Human Gastric Cancer

Relationship between the CXC Chemokine Receptor-4 /CXCL12 Signal Transduction Pathway and Lymph Node Metastasis of Gastric Carcinoma

Expression Status of S100A14 and S100A4 Correlates with Metastatic Potential and Clinical Outcome in Colorectal Cancer after Surgery.

S100P as a marker for poor survival and advanced stage in gallbladder carcinoma

Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metastases

Expression and Clinical Significance of S100 Calcium Binding Protein A2 in Lung Cancer